MEDRX CO., LTD Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 131 JPY | +4,80% |
|
+14,91% | -13,25% |
Totale waarde
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 5.699 | 4.139 | 3.949 | 3.148 | 2.665 | 5.793 |
| Bedrijfswaarde 1 | 3.903 | 2.729 | 2.187 | 1.445 | 1.671 | 4.073 |
| K/w-verhouding | -4,4 x | -2,26 x | -3,08 x | -2,58 x | -2,17 x | -5,63 x |
| Dividendrendement | - | - | - | - | - | - |
| Marktkapitalisatie/omzet | 712 x | 24,5 x | 34,3 x | 394 x | 45,2 x | 200 x |
| Bedrijfswaarde/omzet | 488 x | 16,1 x | 19 x | 181 x | 28,3 x | 140 x |
| Bedrijfswaarde/EBITDA | -3,16 x | -1,72 x | -2,1 x | -1,44 x | -1,58 x | -4,58 x |
| Bedrijfswaarde/FCF | -5,15 x | -2,21 x | -3,14 x | -2,73 x | -2,56 x | -7,15 x |
| FCF Yield | -19,4% | -45,2% | -31,8% | -36,7% | -39% | -14% |
| Price to Book | 2,67 x | 2,17 x | 1,91 x | 1,61 x | 2,21 x | 3,01 x |
| Aantal aandelen (in duizenden) | 10.214 | 13.614 | 18.715 | 24.595 | 28.054 | 38.365 |
| Referentieprijs 2 | 558,0 | 304,0 | 211,0 | 128,0 | 95,00 | 151,0 |
| Datum van publicatie | 27/03/19 | 30/03/20 | 29/03/21 | 31/03/22 | 28/03/23 | 29/03/24 |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Omzet 1 | 8 | 169 | 115 | 8 | 59 | 29 |
| EBITDA 1 | -1.234 | -1.588 | -1.041 | -1.001 | -1.055 | -889 |
| Bedrijfsresultaat (EBIT) 1 | -1.273 | -1.628 | -1.096 | -1.061 | -1.101 | -934 |
| Operationele Marge | -15.912,5% | -963,31% | -953,04% | -13.262,5% | -1.866,1% | -3.220,69% |
| Resultaat voor belastingen (EBT) 1 | -1.265 | -1.612 | -1.106 | -1.058 | -1.110 | -930 |
| Nettowinst (verlies) 1 | -1.267 | -1.616 | -1.114 | -1.059 | -1.111 | -932 |
| Nettomarge | -15.837,5% | -956,21% | -968,7% | -13.237,5% | -1.883,05% | -3.213,79% |
| WPA 2 | -126,7 | -134,3 | -68,57 | -49,58 | -43,80 | -26,80 |
| Free Cash Flow 1 | -758,6 | -1.234 | -696 | -529,8 | -652,1 | -569,8 |
| FCF-marge | -9.482,81% | -729,88% | -605,22% | -6.621,88% | -1.105,3% | -1.964,66% |
| Kasstroomconversie (ebitda) | - | - | - | - | - | - |
| Kasstroomconversie (nettowinst) | - | - | - | - | - | - |
| Dividend per aandeel | - | - | - | - | - | - |
| Datum van publicatie | 27/03/19 | 30/03/20 | 29/03/21 | 31/03/22 | 28/03/23 | 29/03/24 |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2020 S1 | 2021 S1 | 2021 Q3 | 2022 Q1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Omzet | 15 | 7 | 1 | 1 | 9 | - | 6 | 6 | 23 | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | -706 | -471 | -204 | -189 | -374 | -247 | -294 | -478 | -192 | -176 |
| Operationele Marge | -4.706,67% | -6.728,57% | -20.400% | -18.900% | -4.155,56% | - | -4.900% | -7.966,67% | -834,78% | - |
| Resultaat voor belastingen (EBT) 1 | -707 | -471 | -204 | -196 | -380 | -253 | -289 | -480 | -188 | -127 |
| Nettowinst (verlies) 1 | -713 | -473 | -204 | -196 | -381 | -254 | -290 | -481 | -190 | -128 |
| Nettomarge | -4.753,33% | -6.757,14% | -20.400% | -19.600% | -4.233,33% | - | -4.833,33% | -8.016,67% | -826,09% | - |
| WPA 2 | -47,11 | -23,94 | -8,990 | -8,010 | -15,50 | -10,32 | -9,610 | -14,97 | -5,030 | -3,330 |
| Dividend per aandeel | - | - | - | - | - | - | - | - | - | - |
| Datum van publicatie | 6/08/20 | 10/08/21 | 12/11/21 | 13/05/22 | 10/08/22 | 11/11/22 | 12/05/23 | 10/08/23 | 10/11/23 | 10/05/24 |
1JPY in Miljoen2JPY
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | - | - |
| Nettokaspositie 1 | 1.796 | 1.410 | 1.762 | 1.703 | 994 | 1.720 |
| Hefboom (schuld/ebitda) | - | - | - | - | - | - |
| Free Cash Flow 1 | -759 | -1.234 | -696 | -530 | -652 | -570 |
| ROE (netto-inkomsten/eigen vermogen) | -60,8% | -79,8% | -54,8% | -51,6% | -70,2% | -59,5% |
| ROA (netto-inkomsten/totale activa) | -35,8% | -46,7% | -31,5% | -30,1% | -39,3% | -33,8% |
| Totale activa 1 | 3.538 | 3.461 | 3.532 | 3.517 | 2.830 | 2.754 |
| Nettoactief per aandeel 2 | 209,0 | 140,0 | 110,0 | 79,50 | 42,90 | 50,10 |
| Cashflow per aandeel 2 | 176,0 | 103,0 | 93,20 | 69,20 | 35,20 | 44,80 |
| Capex 1 | 42 | 252 | 39 | 2 | 1 | - |
| Capex/omzet | 525% | 149,11% | 33,91% | 25% | 1,69% | - |
| Datum van publicatie | 27/03/19 | 30/03/20 | 29/03/21 | 31/03/22 | 28/03/23 | 29/03/24 |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Historische marktkapitalisatie/EBITDA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -13,25% | 32,96 mln. | |
| +15,09% | 74,45 mld. | |
| +11,35% | 9,18 mld. | |
| +54,35% | 5,03 mld. | |
| -12,85% | 5,02 mld. | |
| +1,60% | 3,82 mld. | |
| -20,85% | 2,41 mld. | |
| +16,88% | 2,39 mld. | |
| -29,25% | 2,27 mld. | |
| +24,62% | 2,26 mld. |
- Beurs
- Aandelen
- Koers 4586
- Financiën MedRx Co., Ltd
